Sales Cambio Fecha
AbbVie USD 14.3B 374M 2023-12
Acorda Therapeutics USD 27.72M 1.96M 2023-09
Agios Pharmaceuticals USD 7.1M 296K 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bluebird Bio USD 12.39M 5.5M 2023-09
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Coherus Biosciences USD 91.52M 16.96M 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 1.01B 94.32M 2023-12
J&J USD 21.4B 44M 2023-12
Merck USD 14.63B 1.33B 2023-12
Moderna USD 2.81B 980M 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.78B 316M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Puma Biotechnology USD 72.18M 16.06M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Sangamo BioSciences USD 2.04M 7.36M 2023-12
Sanofi EUR 10.92B 1.05B 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
United Therapeutics USD 614.7M 5.3M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Gilead Sciences Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.